NIH subsidiary awards Cleveland Clinic $6M for ACL research — 5 insights

The National Institutes of Health’s National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded the Cleveland Clinic a five-year, $6 million grant to examine Bridge-Enhanced ACL Repair outcomes.

Advertisement

Here’s what you should know:

1. Kurt Spindler, MD, will lead a multicenter, randomized clinical trial to examine whether Bridge-Enhanced ACL Repair outcomes are equal to or better than traditional ACL reconstruction.

2. The study will take place at five sites.

3. Researchers are building off existing evidence, which showed the BEAR procedure had similar results to ACL reconstruction.

4. Researchers believe the BEAR implant will increase range of motion and knee kinematics, while eliminating graft harvest morbidity over traditional ACL reconstruction.

5. Dr. Spindler said, “Our goal in this trial is to see if we can duplicate the earlier single-center study results on a multicenter and multisurgeon level. The findings from this trial will hopefully help to change the standard clinical practice of ACL surgery.”

More articles on sports medicine: 
6 anesthesiologists, pain physicians facing criminal charges for murder, fraud & more
12 ASC company leaders to know
Study identifies 5 areas of safe injection practice improvement for ASCs, primary care providers

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.